share_log

Usana Health Sciences Analyst Ratings

Benzinga Analyst Ratings ·  Feb 13, 2023 23:03
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
02/13/2023 -14.05% DA Davidson $49 → $52.5 Maintains Neutral
10/27/2022 -19.78% DA Davidson $57 → $49 Maintains Neutral
07/28/2022 -6.69% DA Davidson $58 → $57 Maintains Neutral
07/12/2022 -5.05% DA Davidson $76 → $58 Maintains Neutral
07/07/2022 -13.24% Jefferies $78 → $53 Downgrades Hold → Underperform
04/27/2022 24.42% DA Davidson $86 → $76 Maintains Neutral
04/14/2022 40.79% DA Davidson → $86 Initiates Coverage On → Neutral
02/10/2021 106.27% Roth Capital $107 → $126 Maintains Buy
12/17/2020 75.17% Roth Capital → $107 Initiates Coverage On → Buy
08/22/2019 6.41% Jefferies → $65 Initiates Coverage On → Hold
07/03/2019 14.59% Sidoti & Co. $108 → $70 Downgrades Buy → Neutral
04/16/2019 Tigress Financial Initiates Coverage On → Buy
04/23/2018 Pivotal Research Downgrades Buy → Hold

What is the target price for Usana Health Sciences (USNA)?

The latest price target for Usana Health Sciences (NYSE: USNA) was reported by DA Davidson on October 27, 2022. The analyst firm set a price target for $49.00 expecting USNA to fall to within 12 months (a possible -19.78% downside). 6 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Usana Health Sciences (USNA)?

The latest analyst rating for Usana Health Sciences (NYSE: USNA) was provided by DA Davidson, and Usana Health Sciences maintained their neutral rating.

When is the next analyst rating going to be posted or updated for Usana Health Sciences (USNA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Usana Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Usana Health Sciences was filed on October 27, 2022 so you should expect the next rating to be made available sometime around October 27, 2023.

Is the Analyst Rating Usana Health Sciences (USNA) correct?

While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $57.00 to $49.00. The current price Usana Health Sciences (USNA) is trading at is $61.09, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment